168 related articles for article (PubMed ID: 2117219)
1. Evaluation of alveolitis by studies of lung biopsies.
Haslam PL
Lung; 1990; 168 Suppl():984-92. PubMed ID: 2117219
[TBL] [Abstract][Full Text] [Related]
2. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.
Campbell DA; Poulter LW; Janossy G; du Bois RM
Thorax; 1985 Jun; 40(6):405-11. PubMed ID: 3875162
[TBL] [Abstract][Full Text] [Related]
4. [Increased oxidative metabolism of alveolar macrophages in idiopathic fibrosing alveolitis].
Steppling H; Nagel M; Strausz J; Müller-Quernheim J
Pneumologie; 1990 Feb; 44 Suppl 1():303-5. PubMed ID: 2367398
[TBL] [Abstract][Full Text] [Related]
5. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM
Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562
[TBL] [Abstract][Full Text] [Related]
6. Usual interstitial pneumonitis is a T-cell alveolitis.
Kradin RL; Divertie MB; Colvin RB; Ramirez J; Ryu J; Carpenter HA; Bhan AK
Clin Immunol Immunopathol; 1986 Aug; 40(2):224-35. PubMed ID: 3521973
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.
Pantelidis P; Southcott AM; Black CM; Du Bois RM
Clin Exp Immunol; 1997 Apr; 108(1):95-104. PubMed ID: 9097917
[TBL] [Abstract][Full Text] [Related]
8. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
10. Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.
Matsuyama W; Kawabata M; Mizoguchi A; Iwami F; Wakimoto J; Osame M
Clin Exp Immunol; 2003 Sep; 133(3):397-403. PubMed ID: 12930367
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic studies in fibrosing alveolitis. I. Content of alveolar macrophages and lymphocytes in lung parenchyma in correlation with the duration of the disease].
Eckert H; Dvorakovskaja IW; Jerochin WW; Chernjakova DN
Z Erkr Atmungsorgane; 1988; 170(2):167-71. PubMed ID: 3400289
[TBL] [Abstract][Full Text] [Related]
12. [Scleroderma and alveolar inflammation].
Crestani B; Aubier M
Rev Mal Respir; 1996; 13(1):15-20. PubMed ID: 8650411
[TBL] [Abstract][Full Text] [Related]
13. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.
Wallace WA; Schofield JA; Lamb D; Howie SE
Thorax; 1994 Nov; 49(11):1139-45. PubMed ID: 7831631
[TBL] [Abstract][Full Text] [Related]
14. Structural features of interstitial lung disease in systemic sclerosis.
Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
[TBL] [Abstract][Full Text] [Related]
15. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
Haslam PL; Parker DJ; Townsend PJ
Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.
Corrin B; Butcher D; McAnulty BJ; Dubois RM; Black CM; Laurent GJ; Harrison NK
Histopathology; 1994 Feb; 24(2):145-50. PubMed ID: 8181807
[TBL] [Abstract][Full Text] [Related]
18. The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis.
Noble B; Du Bois RM; Poulter LW
Clin Exp Immunol; 1989 Apr; 76(1):41-6. PubMed ID: 2736799
[TBL] [Abstract][Full Text] [Related]
19. [The current concepts of the pathogenesis of fibrosing alveolitis].
Shukurova RA
Ter Arkh; 1992; 64(1):151-5. PubMed ID: 1523555
[No Abstract] [Full Text] [Related]
20. Alveolar macrophage lysosomal enzyme and C3b receptors in cryptogenic fibrosing alveolitis.
du Bois RM; Townsend PJ; Cole PJ
Clin Exp Immunol; 1980 Apr; 40(1):60-5. PubMed ID: 7389217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
